Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SAGE Therapeutics describes new GABA-A receptor modulators

June 27, 2022

Mindset Pharma collaborates with CAMH on preclinical evaluation of MSP-1014

June 23, 2022

Data in mice support potential of ATL-1102 for limb girdle muscular dystrophy R2

June 23, 2022

A novel Smad4-mutated mouse model of Myhre Syndrome

June 23, 2022

Katholieke Universiteit Leuven describes new TRPM3 antagonists

June 23, 2022

Lenire licenses VSN-16R from UCL for fragile X syndrome

June 20, 2022

Merck & Co. patents orexin OX2 receptor agonists

June 16, 2022

Vanderbilt University patents new muscarinic M4 receptor antagonists

June 15, 2022

Alpha Cognition announces discovery of GEM combinations ALPHA-0702 and ALPHA-0802

June 14, 2022

Astrocyte-specific IL-2 delivery shows neuroprotective effect in four neuroinflammation models

June 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....